Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Return on Sales (2016 - 2025)

Standard Biotools (LAB) has disclosed Return on Sales for 16 consecutive years, with 2.94% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Sales rose 15.0% to 2.94% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.66%, a 15.0% decrease, with the full-year FY2024 number at 0.8%, down 41.0% from a year prior.
  • Return on Sales was 2.94% for Q3 2025 at Standard Biotools, up from 0.81% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 5.67% in Q4 2022 to a low of 3.38% in Q2 2022.
  • A 5-year average of 0.18% and a median of 0.62% in 2023 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: surged 592bps in 2022, then tumbled -518bps in 2023.
  • Standard Biotools' Return on Sales stood at 0.25% in 2021, then surged by 2401bps to 5.67% in 2022, then plummeted by -91bps to 0.49% in 2023, then crashed by -213bps to 0.55% in 2024, then skyrocketed by 636bps to 2.94% in 2025.
  • Per Business Quant, the three most recent readings for LAB's Return on Sales are 2.94% (Q3 2025), 0.81% (Q2 2025), and 0.8% (Q1 2025).